Rank | Gene Set | Z-score |
---|---|---|
1 | actin-myosin filament sliding (GO:0033275) | 9.27097564 |
2 | muscle filament sliding (GO:0030049) | 9.27097564 |
3 | sarcomere organization (GO:0045214) | 8.74837016 |
4 | regulation of skeletal muscle contraction (GO:0014819) | 8.64772294 |
5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.81943324 |
6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.74994325 |
7 | actin-mediated cell contraction (GO:0070252) | 7.66274511 |
8 | myofibril assembly (GO:0030239) | 7.50630558 |
9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.26049503 |
10 | cardiac myofibril assembly (GO:0055003) | 7.22147596 |
11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.12163915 |
12 | plasma membrane repair (GO:0001778) | 6.91166476 |
13 | skeletal muscle contraction (GO:0003009) | 6.40932588 |
14 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.31964344 |
15 | regulation of relaxation of muscle (GO:1901077) | 6.17443993 |
16 | cardiac muscle contraction (GO:0060048) | 6.13584954 |
17 | striated muscle contraction (GO:0006941) | 6.06672336 |
18 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.02725745 |
19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.99035095 |
20 | carnitine shuttle (GO:0006853) | 5.95916169 |
21 | regulation of cell communication by electrical coupling (GO:0010649) | 5.89712518 |
22 | tricarboxylic acid cycle (GO:0006099) | 5.84837602 |
23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.80459585 |
24 | actin filament-based movement (GO:0030048) | 5.75753155 |
25 | skeletal muscle adaptation (GO:0043501) | 5.65188145 |
26 | actomyosin structure organization (GO:0031032) | 5.62136742 |
27 | regulation of actin filament-based movement (GO:1903115) | 5.56684592 |
28 | cardiac muscle cell development (GO:0055013) | 5.48539697 |
29 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.45578710 |
30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.30963714 |
31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.28503771 |
32 | fatty acid transmembrane transport (GO:1902001) | 5.15880138 |
33 | cardiac cell development (GO:0055006) | 5.14717040 |
34 | creatine metabolic process (GO:0006600) | 5.12377137 |
35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.07835018 |
36 | cardiac muscle hypertrophy (GO:0003300) | 4.81884607 |
37 | regulation of cofactor metabolic process (GO:0051193) | 4.77711801 |
38 | regulation of coenzyme metabolic process (GO:0051196) | 4.77711801 |
39 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.73592019 |
40 | regulation of striated muscle contraction (GO:0006942) | 4.73096800 |
41 | striated muscle hypertrophy (GO:0014897) | 4.72589146 |
42 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.58243060 |
43 | regulation of sarcomere organization (GO:0060297) | 4.50317135 |
44 | heart contraction (GO:0060047) | 4.49058651 |
45 | heart process (GO:0003015) | 4.49058651 |
46 | muscle contraction (GO:0006936) | 4.46184535 |
47 | adult heart development (GO:0007512) | 4.44278744 |
48 | response to inactivity (GO:0014854) | 4.43945620 |
49 | carnitine transmembrane transport (GO:1902603) | 4.41368928 |
50 | regulation of membrane repolarization (GO:0060306) | 4.31634279 |
51 | myotube cell development (GO:0014904) | 4.30252612 |
52 | muscle tissue morphogenesis (GO:0060415) | 4.27800080 |
53 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.26585624 |
54 | glycogen catabolic process (GO:0005980) | 4.24437564 |
55 | muscle hypertrophy (GO:0014896) | 4.16433594 |
56 | striated muscle adaptation (GO:0014888) | 4.12631636 |
57 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.11772699 |
58 | muscle system process (GO:0003012) | 4.10241124 |
59 | response to muscle activity (GO:0014850) | 4.09161117 |
60 | striated muscle atrophy (GO:0014891) | 4.08298446 |
61 | amino-acid betaine transport (GO:0015838) | 4.02403903 |
62 | carnitine transport (GO:0015879) | 4.02403903 |
63 | heart trabecula formation (GO:0060347) | 3.98932942 |
64 | glucan catabolic process (GO:0009251) | 3.95648139 |
65 | regulation of sulfur metabolic process (GO:0042762) | 3.92020857 |
66 | skeletal muscle tissue development (GO:0007519) | 3.85957753 |
67 | striated muscle cell development (GO:0055002) | 3.85580917 |
68 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.84065574 |
69 | muscle cell cellular homeostasis (GO:0046716) | 3.80600147 |
70 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.79943951 |
71 | cell communication involved in cardiac conduction (GO:0086065) | 3.78456838 |
72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.74512068 |
73 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.74357451 |
74 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.74357451 |
75 | muscle fiber development (GO:0048747) | 3.74113974 |
76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.73322899 |
77 | relaxation of cardiac muscle (GO:0055119) | 3.72656063 |
78 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.70105938 |
79 | cellular polysaccharide catabolic process (GO:0044247) | 3.69399640 |
80 | regulation of sequestering of triglyceride (GO:0010889) | 3.64634076 |
81 | positive regulation of cation channel activity (GO:2001259) | 3.61629146 |
82 | NADH metabolic process (GO:0006734) | 3.61621886 |
83 | response to caffeine (GO:0031000) | 3.58491018 |
84 | cytidine deamination (GO:0009972) | 3.56039182 |
85 | cytidine metabolic process (GO:0046087) | 3.56039182 |
86 | cytidine catabolic process (GO:0006216) | 3.56039182 |
87 | cardiac muscle cell action potential (GO:0086001) | 3.54731481 |
88 | skeletal muscle tissue regeneration (GO:0043403) | 3.53347889 |
89 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.52896005 |
90 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.52896005 |
91 | regulation of heart rate (GO:0002027) | 3.51241970 |
92 | polysaccharide catabolic process (GO:0000272) | 3.50769346 |
93 | glycogen biosynthetic process (GO:0005978) | 3.49925798 |
94 | glucan biosynthetic process (GO:0009250) | 3.49925798 |
95 | relaxation of muscle (GO:0090075) | 3.49843351 |
96 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.49494388 |
97 | response to epinephrine (GO:0071871) | 3.48522618 |
98 | muscle atrophy (GO:0014889) | 3.47978073 |
99 | regulation of cardiac muscle contraction (GO:0055117) | 3.47584378 |
100 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.46658856 |
101 | regulation of the force of heart contraction (GO:0002026) | 3.46240081 |
102 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.41062428 |
103 | muscle adaptation (GO:0043500) | 3.41042966 |
104 | negative regulation of potassium ion transport (GO:0043267) | 3.40590965 |
105 | regulation of muscle contraction (GO:0006937) | 3.39555887 |
106 | cardiac muscle adaptation (GO:0014887) | 3.37634584 |
107 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.37634584 |
108 | muscle hypertrophy in response to stress (GO:0003299) | 3.37634584 |
109 | muscle cell development (GO:0055001) | 3.37620337 |
110 | skeletal muscle fiber development (GO:0048741) | 3.37316946 |
111 | negative regulation of protein localization to cell surface (GO:2000009) | 3.36088945 |
112 | * regulation of muscle system process (GO:0090257) | 3.33044408 |
113 | regulation of ATPase activity (GO:0043462) | 3.32828293 |
114 | regulation of ATP catabolic process (GO:1903289) | 3.32828293 |
115 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.32051210 |
116 | muscle structure development (GO:0061061) | 3.29775482 |
117 | cell communication by electrical coupling (GO:0010644) | 3.29094322 |
118 | muscle organ development (GO:0007517) | 3.28455687 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.84863912 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.67797107 |
3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.07964720 |
4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.86445187 |
5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.81258807 |
6 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.76235412 |
7 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.76235412 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.44121625 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.07360063 |
10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.84685652 |
11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.66024158 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44440154 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.35135311 |
14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.33553069 |
15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.29600185 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17213371 |
17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.16471276 |
18 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.07592705 |
19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87108016 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86332335 |
21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66358480 |
22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.61778738 |
23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61654610 |
24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.58241845 |
25 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.55613795 |
26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54125679 |
27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50749614 |
28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47327737 |
29 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.47165805 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45966102 |
31 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.42838564 |
32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39902550 |
33 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31000340 |
34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30929478 |
35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30421763 |
36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29987911 |
37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21399991 |
38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20640908 |
39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19776053 |
40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17391466 |
41 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16971907 |
42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16743577 |
43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16225449 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15565804 |
45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15015381 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13852830 |
47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11824306 |
48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10793425 |
49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10427432 |
50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10329260 |
51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10210755 |
52 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09819197 |
53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09274006 |
54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09012199 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08583447 |
56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07797799 |
57 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06801748 |
58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04051952 |
59 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03666061 |
60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03464585 |
61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02692684 |
62 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02636350 |
63 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01877633 |
64 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.01447781 |
65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00641628 |
66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99576098 |
67 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98786488 |
68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98757864 |
69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97875661 |
70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97873948 |
71 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96658957 |
72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95697475 |
73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94048957 |
74 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93352276 |
75 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93187040 |
76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93015692 |
77 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92992276 |
78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92694764 |
79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92635845 |
80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91605092 |
81 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91472828 |
82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91001789 |
83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90895254 |
84 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89681749 |
85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89535003 |
86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88885531 |
87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88527747 |
88 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88284848 |
89 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88165949 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87396414 |
91 | P68_20966046_ChIP-Seq_HELA_Human | 0.87210464 |
92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86729492 |
93 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.86678818 |
94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86311256 |
95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.86303947 |
96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86236454 |
97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86236198 |
98 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85976132 |
99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85759486 |
100 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85728884 |
101 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.85388039 |
102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85203383 |
103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85170196 |
104 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85094426 |
105 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84005213 |
106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83838674 |
107 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83185214 |
108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82875333 |
109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82413614 |
110 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81723074 |
111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81648303 |
112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80778233 |
113 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.80539635 |
114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79560887 |
115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79439036 |
116 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79403774 |
117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79253411 |
118 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79229917 |
119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78914796 |
120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78895324 |
121 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.78782138 |
122 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.78782138 |
123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78610373 |
124 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.78508731 |
125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78407958 |
126 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.78068503 |
127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77953985 |
128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77953985 |
129 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77295000 |
130 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.76994401 |
131 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76941119 |
132 | TCF4_23295773_ChIP-Seq_U87_Human | 0.76706330 |
133 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.76255947 |
134 | TBL1_22424771_ChIP-Seq_293T_Human | 0.76099470 |
135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75296277 |
136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74969535 |
137 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74844219 |
138 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.74754344 |
139 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74058078 |
140 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73277593 |
141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73137839 |
142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.71827468 |
143 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.70773674 |
144 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70367786 |
145 | SA1_27219007_Chip-Seq_Bcells_Human | 0.70220374 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 6.55857539 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 6.04692752 |
3 | MP0000751_myopathy | 5.62271758 |
4 | MP0000749_muscle_degeneration | 4.96026904 |
5 | MP0004145_abnormal_muscle_electrophysio | 4.51569724 |
6 | MP0004084_abnormal_cardiac_muscle | 4.46977618 |
7 | MP0004036_abnormal_muscle_relaxation | 4.32450601 |
8 | MP0004215_abnormal_myocardial_fiber | 3.94703924 |
9 | MP0004087_abnormal_muscle_fiber | 3.37753870 |
10 | MP0005330_cardiomyopathy | 3.36379846 |
11 | MP0002106_abnormal_muscle_physiology | 3.31112140 |
12 | MP0004130_abnormal_muscle_cell | 3.11939341 |
13 | MP0000750_abnormal_muscle_regeneration | 3.07370453 |
14 | MP0005620_abnormal_muscle_contractility | 2.99598437 |
15 | MP0000747_muscle_weakness | 2.98431908 |
16 | MP0002269_muscular_atrophy | 2.88934177 |
17 | MP0000759_abnormal_skeletal_muscle | 2.73959223 |
18 | MP0005369_muscle_phenotype | 2.71307899 |
19 | MP0002972_abnormal_cardiac_muscle | 2.60627492 |
20 | MP0004484_altered_response_of | 2.35417398 |
21 | MP0008775_abnormal_heart_ventricle | 2.26148837 |
22 | MP0003137_abnormal_impulse_conducting | 2.24273426 |
23 | MP0010630_abnormal_cardiac_muscle | 2.22317308 |
24 | MP0001544_abnormal_cardiovascular_syste | 2.10271027 |
25 | MP0005385_cardiovascular_system_phenoty | 2.10271027 |
26 | MP0004233_abnormal_muscle_weight | 2.03747120 |
27 | MP0006036_abnormal_mitochondrial_physio | 1.82658050 |
28 | MP0004510_myositis | 1.80505319 |
29 | MP0002332_abnormal_exercise_endurance | 1.79985027 |
30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.77265529 |
31 | MP0006138_congestive_heart_failure | 1.73977618 |
32 | MP0005666_abnormal_adipose_tissue | 1.58303696 |
33 | MP0004085_abnormal_heartbeat | 1.54041426 |
34 | MP0003828_pulmonary_edema | 1.53333475 |
35 | MP0003950_abnormal_plasma_membrane | 1.44617271 |
36 | MP0004185_abnormal_adipocyte_glucose | 1.40432933 |
37 | MP0001661_extended_life_span | 1.36293117 |
38 | MP0002108_abnormal_muscle_morphology | 1.35473829 |
39 | MP0002127_abnormal_cardiovascular_syste | 1.33430618 |
40 | MP0000733_abnormal_muscle_development | 1.29874784 |
41 | MP0005670_abnormal_white_adipose | 1.26133508 |
42 | MP0005375_adipose_tissue_phenotype | 1.10106094 |
43 | MP0000343_altered_response_to | 1.05393236 |
44 | MP0006035_abnormal_mitochondrial_morpho | 1.01847364 |
45 | MP0000266_abnormal_heart_morphology | 0.96971251 |
46 | MP0002234_abnormal_pharynx_morphology | 0.94802104 |
47 | MP0005266_abnormal_metabolism | 0.91345862 |
48 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91180630 |
49 | MP0002971_abnormal_brown_adipose | 0.89402136 |
50 | MP0005165_increased_susceptibility_to | 0.83161202 |
51 | MP0003705_abnormal_hypodermis_morpholog | 0.82664228 |
52 | MP0000013_abnormal_adipose_tissue | 0.77230447 |
53 | MP0005275_abnormal_skin_tensile | 0.75041942 |
54 | MP0003806_abnormal_nucleotide_metabolis | 0.70849285 |
55 | MP0010368_abnormal_lymphatic_system | 0.69224870 |
56 | MP0000003_abnormal_adipose_tissue | 0.65004204 |
57 | MP0000230_abnormal_systemic_arterial | 0.63404270 |
58 | MP0004043_abnormal_pH_regulation | 0.62935442 |
59 | MP0003279_aneurysm | 0.61822200 |
60 | MP0002128_abnormal_blood_circulation | 0.60778414 |
61 | MP0004147_increased_porphyrin_level | 0.57244026 |
62 | MP0002078_abnormal_glucose_homeostasis | 0.55128529 |
63 | MP0003045_fibrosis | 0.54275776 |
64 | MP0008961_abnormal_basal_metabolism | 0.51410635 |
65 | MP0005451_abnormal_body_composition | 0.50623536 |
66 | MP0005187_abnormal_penis_morphology | 0.48183886 |
67 | MP0003566_abnormal_cell_adhesion | 0.47802255 |
68 | MP0000372_irregular_coat_pigmentation | 0.46990979 |
69 | MP0008438_abnormal_cutaneous_collagen | 0.46207444 |
70 | MP0005334_abnormal_fat_pad | 0.45791051 |
71 | MP0002909_abnormal_adrenal_gland | 0.42798255 |
72 | MP0002638_abnormal_pupillary_reflex | 0.40785654 |
73 | MP0001879_abnormal_lymphatic_vessel | 0.40290919 |
74 | MP0005319_abnormal_enzyme/_coenzyme | 0.39789216 |
75 | MP0000579_abnormal_nail_morphology | 0.39204792 |
76 | MP0000767_abnormal_smooth_muscle | 0.37162783 |
77 | MP0005623_abnormal_meninges_morphology | 0.35036438 |
78 | MP0005167_abnormal_blood-brain_barrier | 0.34364420 |
79 | MP0003879_abnormal_hair_cell | 0.34192182 |
80 | MP0001299_abnormal_eye_distance/ | 0.31904134 |
81 | MP0005535_abnormal_body_temperature | 0.31762308 |
82 | MP0009672_abnormal_birth_weight | 0.31741067 |
83 | MP0002925_abnormal_cardiovascular_devel | 0.31225704 |
84 | MP0009115_abnormal_fat_cell | 0.31075434 |
85 | MP0004134_abnormal_chest_morphology | 0.30993958 |
86 | MP0003656_abnormal_erythrocyte_physiolo | 0.30765418 |
87 | MP0003948_abnormal_gas_homeostasis | 0.30369515 |
88 | MP0001984_abnormal_olfaction | 0.30046008 |
89 | MP0005452_abnormal_adipose_tissue | 0.27267489 |
90 | MP0004270_analgesia | 0.27259347 |
91 | MP0004142_abnormal_muscle_tone | 0.26513307 |
92 | MP0003941_abnormal_skin_development | 0.25072596 |
93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.24932379 |
94 | MP0008569_lethality_at_weaning | 0.24922774 |
95 | MP0001614_abnormal_blood_vessel | 0.24633401 |
96 | MP0001784_abnormal_fluid_regulation | 0.24006856 |
97 | MP0002118_abnormal_lipid_homeostasis | 0.23976483 |
98 | MP0009780_abnormal_chondrocyte_physiolo | 0.23052569 |
99 | MP0009384_cardiac_valve_regurgitation | 0.22828615 |
100 | MP0001853_heart_inflammation | 0.21128123 |
101 | MP0004924_abnormal_behavior | 0.20995806 |
102 | MP0005386_behavior/neurological_phenoty | 0.20995806 |
103 | MP0002114_abnormal_axial_skeleton | 0.20768304 |
104 | MP0005423_abnormal_somatic_nervous | 0.20113195 |
105 | MP0000762_abnormal_tongue_morphology | 0.19977422 |
106 | MP0004272_abnormal_basement_membrane | 0.19897837 |
107 | MP0002877_abnormal_melanocyte_morpholog | 0.19203860 |
108 | MP0009250_abnormal_appendicular_skeleto | 0.18213742 |
109 | MP0002822_catalepsy | 0.17458222 |
110 | MP0003195_calcinosis | 0.16932660 |
111 | MP0005166_decreased_susceptibility_to | 0.16719872 |
112 | MP0005083_abnormal_biliary_tract | 0.16676269 |
113 | MP0005332_abnormal_amino_acid | 0.16585977 |
114 | MP0002970_abnormal_white_adipose | 0.15865412 |
115 | MP0005376_homeostasis/metabolism_phenot | 0.15752006 |
116 | MP0002896_abnormal_bone_mineralization | 0.15729021 |
117 | MP0003984_embryonic_growth_retardation | 0.15589217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 7.75075711 |
2 | Exercise-induced muscle cramps (HP:0003710) | 7.29470330 |
3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.94844488 |
4 | Calf muscle hypertrophy (HP:0008981) | 6.92536854 |
5 | Sudden death (HP:0001699) | 6.50719276 |
6 | Muscle fiber inclusion bodies (HP:0100299) | 6.46907678 |
7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.25839186 |
8 | Muscle fiber splitting (HP:0003555) | 6.13963413 |
9 | Nemaline bodies (HP:0003798) | 5.58511139 |
10 | Myoglobinuria (HP:0002913) | 5.57801041 |
11 | Hyporeflexia of lower limbs (HP:0002600) | 5.36208107 |
12 | Ventricular tachycardia (HP:0004756) | 5.27448417 |
13 | Abnormality of the calf musculature (HP:0001430) | 5.25594510 |
14 | Type 1 muscle fiber predominance (HP:0003803) | 5.13574230 |
15 | Difficulty running (HP:0009046) | 4.86847369 |
16 | EMG: myopathic abnormalities (HP:0003458) | 4.75480216 |
17 | Increased connective tissue (HP:0009025) | 4.66658238 |
18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.49533547 |
19 | Subaortic stenosis (HP:0001682) | 4.49533547 |
20 | Rhabdomyolysis (HP:0003201) | 4.43643868 |
21 | Distal arthrogryposis (HP:0005684) | 4.42127499 |
22 | Atrial fibrillation (HP:0005110) | 4.23544017 |
23 | Myotonia (HP:0002486) | 4.08225058 |
24 | Lipoatrophy (HP:0100578) | 4.04988767 |
25 | Primary atrial arrhythmia (HP:0001692) | 3.95149137 |
26 | Myopathic facies (HP:0002058) | 3.91998787 |
27 | Right ventricular cardiomyopathy (HP:0011663) | 3.84979432 |
28 | Round ear (HP:0100830) | 3.81106173 |
29 | Supraventricular tachycardia (HP:0004755) | 3.80869192 |
30 | Muscle stiffness (HP:0003552) | 3.76474875 |
31 | Supraventricular arrhythmia (HP:0005115) | 3.72446966 |
32 | Asymmetric septal hypertrophy (HP:0001670) | 3.67570955 |
33 | Bundle branch block (HP:0011710) | 3.61814070 |
34 | Dilated cardiomyopathy (HP:0001644) | 3.49491859 |
35 | Difficulty climbing stairs (HP:0003551) | 3.43852067 |
36 | Syncope (HP:0001279) | 3.39822996 |
37 | Ulnar deviation of the wrist (HP:0003049) | 3.34066892 |
38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.32357227 |
39 | Increased variability in muscle fiber diameter (HP:0003557) | 3.25007301 |
40 | Palpitations (HP:0001962) | 3.19241579 |
41 | Neck muscle weakness (HP:0000467) | 3.16832225 |
42 | Rimmed vacuoles (HP:0003805) | 3.09370702 |
43 | Areflexia of lower limbs (HP:0002522) | 3.06618813 |
44 | Prolonged QT interval (HP:0001657) | 3.05792332 |
45 | Ventricular arrhythmia (HP:0004308) | 3.02334887 |
46 | Heart block (HP:0012722) | 2.95419286 |
47 | Abnormal atrioventricular conduction (HP:0005150) | 2.79797194 |
48 | Distal lower limb muscle weakness (HP:0009053) | 2.77956767 |
49 | Calcaneovalgus deformity (HP:0001848) | 2.75046499 |
50 | Atrioventricular block (HP:0001678) | 2.65206694 |
51 | Absent phalangeal crease (HP:0006109) | 2.56288959 |
52 | Deformed tarsal bones (HP:0008119) | 2.50709115 |
53 | Hypoplastic ischia (HP:0003175) | 2.49955086 |
54 | Ventricular fibrillation (HP:0001663) | 2.48851874 |
55 | Frequent falls (HP:0002359) | 2.47194155 |
56 | Muscular dystrophy (HP:0003560) | 2.41688193 |
57 | Limb-girdle muscle atrophy (HP:0003797) | 2.40130556 |
58 | EMG: neuropathic changes (HP:0003445) | 2.36049006 |
59 | Fetal akinesia sequence (HP:0001989) | 2.35463005 |
60 | Facial diplegia (HP:0001349) | 2.29757658 |
61 | Ragged-red muscle fibers (HP:0003200) | 2.27402290 |
62 | Left ventricular hypertrophy (HP:0001712) | 2.25315913 |
63 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24158720 |
64 | Slender build (HP:0001533) | 2.23955760 |
65 | Generalized muscle weakness (HP:0003324) | 2.22360339 |
66 | Distal lower limb amyotrophy (HP:0008944) | 2.21251929 |
67 | Abnormal EKG (HP:0003115) | 2.20959474 |
68 | Abnormality of the ischium (HP:0003174) | 2.18644111 |
69 | Gowers sign (HP:0003391) | 2.17039750 |
70 | Ketoacidosis (HP:0001993) | 2.15404117 |
71 | Proximal amyotrophy (HP:0007126) | 2.14610142 |
72 | Weak cry (HP:0001612) | 2.11284588 |
73 | Scapular winging (HP:0003691) | 2.10841929 |
74 | Abnormal finger flexion creases (HP:0006143) | 2.08256617 |
75 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.06613552 |
76 | Malignant hyperthermia (HP:0002047) | 2.06022268 |
77 | Hepatic necrosis (HP:0002605) | 2.05029636 |
78 | Hip contracture (HP:0003273) | 2.04441668 |
79 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.03230719 |
80 | Palmoplantar keratoderma (HP:0000982) | 2.03030485 |
81 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01028066 |
82 | Waddling gait (HP:0002515) | 2.00666313 |
83 | Hyperkalemia (HP:0002153) | 2.00296387 |
84 | Lower limb amyotrophy (HP:0007210) | 1.99614520 |
85 | Testicular atrophy (HP:0000029) | 1.97996179 |
86 | Limb-girdle muscle weakness (HP:0003325) | 1.96527228 |
87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.95866605 |
88 | Acute necrotizing encephalopathy (HP:0006965) | 1.94866817 |
89 | Increased muscle lipid content (HP:0009058) | 1.92048471 |
90 | Abnormality of the neuromuscular junction (HP:0003398) | 1.90267501 |
91 | Fatigable weakness (HP:0003473) | 1.90267501 |
92 | Progressive muscle weakness (HP:0003323) | 1.89554909 |
93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.88943984 |
94 | Abnormality of alanine metabolism (HP:0010916) | 1.88943984 |
95 | Hyperalaninemia (HP:0003348) | 1.88943984 |
96 | Foot dorsiflexor weakness (HP:0009027) | 1.86120139 |
97 | Steppage gait (HP:0003376) | 1.84675767 |
98 | Abnormality of the foot musculature (HP:0001436) | 1.84466071 |
99 | Exercise intolerance (HP:0003546) | 1.84019938 |
100 | Spinal rigidity (HP:0003306) | 1.83683084 |
101 | Toxemia of pregnancy (HP:0100603) | 1.83130024 |
102 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.82802463 |
103 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.82802463 |
104 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82754103 |
105 | Hypoglycemic coma (HP:0001325) | 1.81686707 |
106 | Conjunctival hamartoma (HP:0100780) | 1.79833150 |
107 | Bulbar palsy (HP:0001283) | 1.79275727 |
108 | Hepatocellular necrosis (HP:0001404) | 1.77038970 |
109 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74948629 |
110 | Pelvic girdle muscle weakness (HP:0003749) | 1.74794330 |
111 | Oligomenorrhea (HP:0000876) | 1.74572908 |
112 | Abnormality of the calcaneus (HP:0008364) | 1.70918594 |
113 | Diaphragmatic weakness (HP:0009113) | 1.55924381 |
114 | Long clavicles (HP:0000890) | 1.52457114 |
115 | Nonprogressive disorder (HP:0003680) | 1.49141424 |
116 | Increased intramyocellular lipid droplets (HP:0012240) | 1.47390296 |
117 | Limited hip movement (HP:0008800) | 1.45459907 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.14244762 |
2 | TTN | 6.35097716 |
3 | PHKG2 | 5.00808830 |
4 | PHKG1 | 5.00808830 |
5 | PDK4 | 3.12623989 |
6 | PDK3 | 3.12623989 |
7 | DMPK | 2.83617514 |
8 | TRIB3 | 2.39478559 |
9 | NEK1 | 2.33752183 |
10 | LMTK2 | 2.33524486 |
11 | PINK1 | 2.26199071 |
12 | PIK3CA | 2.12380170 |
13 | BCKDK | 2.11551802 |
14 | MUSK | 2.09893440 |
15 | PKN2 | 2.08259560 |
16 | PDK2 | 2.02301856 |
17 | NME1 | 1.92128800 |
18 | MYLK | 1.87570404 |
19 | PIK3CG | 1.77065131 |
20 | MAP2K3 | 1.65874416 |
21 | MAP3K7 | 1.61774455 |
22 | STK24 | 1.39787027 |
23 | MARK1 | 1.36696262 |
24 | TIE1 | 1.36686004 |
25 | MAPK12 | 1.30159382 |
26 | GRK7 | 1.15244148 |
27 | LIMK1 | 1.06086110 |
28 | PRKAA2 | 0.97830652 |
29 | PRKAA1 | 0.97254504 |
30 | ZAK | 0.96942813 |
31 | CAMK2D | 0.92865518 |
32 | PRKD1 | 0.91036435 |
33 | MAPKAPK3 | 0.90014255 |
34 | TRPM7 | 0.82739013 |
35 | ILK | 0.81097419 |
36 | INSRR | 0.81084199 |
37 | MAP2K4 | 0.79517540 |
38 | RIPK1 | 0.77701029 |
39 | NEK9 | 0.76101631 |
40 | PAK3 | 0.74586298 |
41 | MAP3K3 | 0.71266593 |
42 | CCNB1 | 0.68689369 |
43 | EPHA3 | 0.68010186 |
44 | ROCK1 | 0.66627629 |
45 | MAP3K5 | 0.62461813 |
46 | ERBB3 | 0.62236910 |
47 | STK38L | 0.61699394 |
48 | PKN1 | 0.58408965 |
49 | MAPK4 | 0.57348981 |
50 | EPHB1 | 0.57217828 |
51 | MOS | 0.57009292 |
52 | MAP2K6 | 0.56553393 |
53 | LATS1 | 0.53332941 |
54 | CAMK2B | 0.51834004 |
55 | SIK1 | 0.50467911 |
56 | CAMK4 | 0.48093619 |
57 | AKT2 | 0.46754834 |
58 | MAP2K1 | 0.46451457 |
59 | CAMK2G | 0.45936504 |
60 | FLT3 | 0.45856075 |
61 | PDGFRA | 0.45276667 |
62 | STK38 | 0.44541136 |
63 | SGK2 | 0.44001274 |
64 | PRKACB | 0.42805607 |
65 | TGFBR2 | 0.42692116 |
66 | STK4 | 0.39889238 |
67 | CAMK2A | 0.38729302 |
68 | WNK1 | 0.37138122 |
69 | MAPK11 | 0.36203471 |
70 | MAP3K6 | 0.35721700 |
71 | DYRK1B | 0.35599572 |
72 | TAOK1 | 0.35542209 |
73 | ROCK2 | 0.35287362 |
74 | NLK | 0.34361517 |
75 | PRKACA | 0.34337485 |
76 | WNK4 | 0.34210280 |
77 | PDPK1 | 0.33289259 |
78 | LATS2 | 0.33226476 |
79 | CDC42BPA | 0.32668844 |
80 | MAP3K13 | 0.31982941 |
81 | PTK6 | 0.30151822 |
82 | PDK1 | 0.28365577 |
83 | SGK1 | 0.27744364 |
84 | PRKACG | 0.27560225 |
85 | CAMK1 | 0.27153091 |
86 | STK11 | 0.26576797 |
87 | MARK2 | 0.26521289 |
88 | PRKG1 | 0.25586954 |
89 | ICK | 0.24220461 |
90 | FGFR3 | 0.23995750 |
91 | MAPK10 | 0.23914862 |
92 | SGK3 | 0.22942245 |
93 | RPS6KA1 | 0.22446343 |
94 | RPS6KL1 | 0.22192277 |
95 | RPS6KC1 | 0.22192277 |
96 | RET | 0.21837464 |
97 | EEF2K | 0.21586449 |
98 | SGK494 | 0.21241150 |
99 | SGK223 | 0.21241150 |
100 | RPS6KA3 | 0.20944790 |
101 | KDR | 0.20481247 |
102 | PTK2B | 0.20046905 |
103 | MAP3K1 | 0.20007926 |
104 | KSR2 | 0.19825324 |
105 | PRKCH | 0.19506245 |
106 | PRKD3 | 0.19417653 |
107 | MAPK7 | 0.19015253 |
108 | MARK3 | 0.18943907 |
109 | RPS6KB1 | 0.18827278 |
110 | MAP3K10 | 0.18629697 |
111 | ZAP70 | 0.17687725 |
112 | MAP3K11 | 0.17393439 |
113 | JAK1 | 0.17021380 |
114 | RPS6KA6 | 0.16667502 |
115 | TBK1 | 0.15418001 |
116 | MTOR | 0.14073835 |
117 | FER | 0.13966114 |
118 | CAMK1G | 0.13878617 |
119 | PAK6 | 0.13799136 |
120 | TAOK2 | 0.13642382 |
121 | RPS6KB2 | 0.13512889 |
122 | PRKCE | 0.12258235 |
123 | DAPK3 | 0.11444173 |
124 | MAP3K4 | 0.09961000 |
125 | JAK2 | 0.08629899 |
126 | PRPF4B | 0.07367006 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.59215185 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.09613076 |
3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.01289694 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.01258974 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.85136778 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.18167164 |
7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.08054464 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06133885 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61661430 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.48381229 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.37664068 |
12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.31812662 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13275022 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99908587 |
15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97986386 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.84300069 |
17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79172173 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73203390 |
19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70106859 |
20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61417664 |
21 | Insulin resistance_Homo sapiens_hsa04931 | 1.50717187 |
22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.46522168 |
23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43010517 |
24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.42423657 |
25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.41586760 |
26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30570232 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22841365 |
28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18980679 |
29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14223241 |
30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14010647 |
31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13618199 |
32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11946712 |
33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06983016 |
34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06887146 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97681495 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97350098 |
37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96480273 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94385547 |
39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84818021 |
40 | Focal adhesion_Homo sapiens_hsa04510 | 0.82703962 |
41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82312199 |
42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79931109 |
43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74533303 |
44 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74347467 |
45 | Tight junction_Homo sapiens_hsa04530 | 0.73123475 |
46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72160798 |
47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70248738 |
48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69841014 |
49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67350024 |
50 | Lysine degradation_Homo sapiens_hsa00310 | 0.66599738 |
51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63771085 |
52 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63682080 |
53 | Renin secretion_Homo sapiens_hsa04924 | 0.59854219 |
54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59581156 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58393258 |
56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56034566 |
57 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55694345 |
58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49955580 |
59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48308783 |
60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48286321 |
61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47760255 |
62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46847554 |
63 | Insulin secretion_Homo sapiens_hsa04911 | 0.46795422 |
64 | Adherens junction_Homo sapiens_hsa04520 | 0.46131247 |
65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45114315 |
66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40637772 |
67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40486520 |
68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38255112 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36668323 |
70 | Peroxisome_Homo sapiens_hsa04146 | 0.36632973 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36110654 |
72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35757599 |
73 | Amoebiasis_Homo sapiens_hsa05146 | 0.34010882 |
74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33868797 |
75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33816185 |
76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33688042 |
77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31479531 |
78 | Platelet activation_Homo sapiens_hsa04611 | 0.30999840 |
79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30835725 |
80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29839061 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29392150 |
82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26079388 |
83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26014792 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25489901 |
85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23702460 |
86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22423022 |
87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22078155 |
88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19593031 |
89 | Long-term depression_Homo sapiens_hsa04730 | 0.19485188 |
90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18998923 |
91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18373011 |
92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17766047 |
93 | Melanogenesis_Homo sapiens_hsa04916 | 0.17313231 |
94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16468465 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13689312 |
96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.13626979 |
97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13594281 |
98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.12461392 |
99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.11697781 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.10496041 |
101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10418023 |
102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09182792 |
103 | Gap junction_Homo sapiens_hsa04540 | 0.08189540 |
104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.06970471 |
105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05604969 |
106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.04148336 |
107 | ABC transporters_Homo sapiens_hsa02010 | 0.03885560 |
108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03278170 |
109 | Bile secretion_Homo sapiens_hsa04976 | 0.03194737 |
110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.02857108 |
111 | Salivary secretion_Homo sapiens_hsa04970 | 0.02157135 |
112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.02044907 |